1. In a preliminary study, a positive pressure of 25 mmHg applied to the lower body raised right atrial pressure by a mean of 7 mmHg.
Introduction
In several studies Epstein [I, 21 and his colleagues have shown that prolonged immersion to the neck in a temperature-controlled water bath causes marked diuresis and natriuresis. Arborelius et al. [31 have demonstrated that such water immersion has marked haemodynamic effects in substantially raising intracardiac filling pressures, cardiac output and redistributing approximately 750 ml of blood into the central circulation.
Other workers have demonstrated that direct stimulation of left atrial receptors [4, 51, or increasing intracardiac filling pressures [6, 71 is associated with marked elevation of sodium and water excretion. More recently, Kass [8l and his colleagues showed that sustained application of lower-body positive pressure (LBPP) in baboons also results in a natriuresis, but this response has a circadian rhythm. The precise mechanism responsible for these changes is uncertain, although it has been suggested that changes in endogenous dopamine production may play a role. Alexander et al.
[91 have shown a rise in urinary dopamine excretion in volume-expanded normal subjects. Ball & Lee [lo] showed that the administration of carbidopa reduced both urinary dopamine and sodium excretion in man, and Brown & Dollery 1111 found that dopamine blockade in DOCA-treated rats substantially attenuated the natriuretic response.
The preliminary study was carried out to show that intracardiac filling pressure could be elevated systematically by applying lower-body positive pressure (LBPP) in a stepwise fashion.
The main study, therefore, was designed to determine whether dopamine blockade could attenuate the natriuretic response associated with an increase in intracardiac filling pressure. It was also designed to examine whether changes in urinary dopamine excretion were related to the natriuretic response.
In addition, a separate control study was carried out to measure the effect of dopamine blockade on basal sodium excretion.
Materials and methods

Preliminary study
A thin Teflon catheter was passed percutaneously to the superior caval right atrial junction in three normal male subjects. Right atrial pressure was recorded by using a Statham P23Db pressure transducer, with mid-thorax taken as zero reference point. Before the introduction of the catheter, the subject was placed in a specially designed plastic bag. The bag allowed the subject to sit in the upright position with the legs dependent. The bag was sealed around the subject just below the costal margin. The bag was then inflated to pressures of 5, 10, 15 and 25 mmHg, a commercial vacuum cleaner reversed to act as a pump being used. Each inflation pressure was maintained for 5-10 min, and right atrial pressure measured at the end of each period.
Main study
Six normal adult male volunteers (aged 18-40 years) were studied. They were put on a diet containing 150 mmol of sodium/24 h. During the subsequent 2 days they continued with normal activities. On the third day of the diet the subjects came to the laboratory at 08.30 hours. For the next 30-40 min they sat comfortably in a chair. They then emptied their bladders, the urine being discarded. The study was then commenced at approximately 09.00 hours. The subjects remained at rest for the next 2 h. Urine was then collected at the end of this period and a blood sample taken. Each subject drank 100 ml of water every hour. On the fourth day, the procedure was repeated except that at 09.00 hours the subject climbed into the plastic bag. The bag was then inflated to a pressure of 30 mmHg, this pressure being maintained for the next 2 h. At this time the bag was deflated and the subject stood up to pass urine, which was collected, and a blood sample taken.
On the fifth day, before bag inflation, 40 mg of domperidone was given by intravenous injection over a 5 rnin period. The same procedure as on the previous day was then repeated.
At a separate time, six subjects were placed on 150 mmol/day sodium diet. On the fourth day the subjects came to the laboratory and rested for 30 min and then emptied their bladders. They were then told that they were to receive an injection of either glucose solution or 40 mg of domperidone. In fact the glucose was always given first. Urine was collected after a 60-90 min period. A bolus of domperidone (40 mg) was then given and a blood sample taken. Further urine collections were made at the end of 90 min.
Urine flow rates were calculated and the urine was analysed for sodium concentration with a Flame 4 autoanalyser. Plasma sodium concentration was measured with the same technique. Urine and plasma creatinine were measured on the same machine. Plasma and urine osmolarity were obtained with an Advanced Instruments Incorporated Osmometer. From these results the following calculations were made: urine flow in ml/min; sodium excretion ("a1 V ) in pmol/min; creatinine clearance (Ccr) in ml/min; osmolar clearance (Cos,,,) in ml/min; free water clearance (C,,) in ml/min; fractional sodium excretion (Ef,,).
A portion (10 ml) of urine was removed from each collection, sufficient hydrochloric acid (6 mol/l) was added to reduce pH to 2-3, and the sample was frozen at -20 OC.
Dopamine was assayed by a modification of the gas chromatographic method described by Wong et al. 1121 . About 5 ml of each urine sample was run in parallel with a duplicate to which 1.5 nmol of dopamine was added as an internal standard.
The addition of an identical amount of isoprenaline to all samples permitted correction for losses during processing. To each sample was added 0-4 ml of EDTA (disodium salt) solution (5 g/100 ml) and 0.2 ml of ascorbic acid solution (10 g/100 ml). In the presence of 0.3 g of activated alumina [131, kept in suspension by continuous rotation of the vial, the pH of the solution was raised to 9.5 with sodium hydroxide solution (2 mol/l). The supernatant and the alumina with the absorbed dopamine were transferred to a small glass column containing an additional 0.2 g of activated alumina. The combined alumina was washed with 10 ml of acetate buffer, pH 9, and 10 ml of water, before the dopamine was eluted in 3 ml of acetic acid (0.5 mol/l).
Freeze-drying of portions (100 pl) of the acetic acid eluate was followed by incubation at 65 "C for 40 min with 20 pl of acetonitrile and 100 pl of pentafluoropropionic anhydride. Excess reagent was evaporated in a stream of nitrogen and the were injected on to a column packed with 10% SE 54 (J.J. Chromatography) on Chromosorb W (HP) 100/120 mesh in a Hewlett Packard 5700 gas chromatograph run isothermally at 200 "C in a 25 ml/min stream of argonhethane carrier gas with 63Ni electron capture detector. Retention times for dopamine and isoprenaline were 6.8 and 7.4 min respectively. Dopamine excretion rate was expressed in nmol/rrtin. Statistical analysis was carried out by Student's paired t test. Fig. 1 shows the change in right atrial pressure as the inflation pressure in the bag was increased. There was a systematic rise in the right atrial pressure as the bag pressure increased so that at a bag pressure of 25 mmHg the mean rise in the atrial pressure was 7 . 7 mmHg. Table 1 significantly greater than control (P = 0.05).
Results
Similarly, CH2? showed no significant change, remaining significantly greater than control value (P = 0.001).
There was no significant difference in mean urinary dopamine excretion during the course of the experiment: control 1.65 f SEM 0.38; LBPP alone 1.76 0.12; LBPP + domperidone 1.34 f 0.26 nmol/min. Table 2 shows the results of domperidone administration on basal sodium excretion: there were no significant changes in any of the variables.
Discussion
The data in our preliminary study confirm that LBPP is a satisfactory method of increasing The changes in sodium and urine excretion found in our study are very similar to those demonstrated by Epstein and his colleagues [ 11, also using water immersion. They showed a progressive rise in sodium excretion over a 5 h period, a much longer time than in the present study. They also showed that the increase in sodium excretion resulted from changes in tubular reabsorption, a result confirmed in the present study, where no change in creatinine clearance was noted. Epstein also demonstrated that the increase in urine flow and CH,O were due to suppression of production of antidiuretic hormone and that diuresis could be entirely abolished by the administration of vasopressin 1141. However, this did not affect natriuresis.
Epstein has discussed the mechanisms responsible for the natriuresis. These include changes in renin-angiotensin activity, in aldosterone production, in Starling forces, redistribution of renal blood flow or alteration of sympathetic tone to the kidney. He concluded that it was unlikely that any of these mechanisms were responsible [141.
He also suggested that a humoral factor may be responsible and he demonstrated that an extract of the urine of subjects undergoing water immersion produced a natriuresis when injected into rats [15]. This is in agreement with the results obtained by Brown et al. [ 161, who demonstrated similar results with volume-expanded animals. It has been suggested that the release of a sodium, potassium-dependent ATPase inhibitor by the hypothalamus may be responsible for this effect [171.
Other workers have suggested that endogenous renal dopamine may play a role in the control of sodium excretion. Alexander et al. 191 demonstrated that normal subjects volumeexpanded with sodium chloride solution (150 mmol/l) showed a tripling of their sodium excretion and a significant increase in urinary dopamine excretion. They also showed a significant relationship between sodium and dopamine excretion in subjects on low and high sodium diets . Faucheux et al. [lS] , however, showed convincingly that volume-expansion with salt-free albumin did not increase urinary sodium or dopamine excretion. Faucheux also showed that the increase in dopamine excretion associated with saline volume-expansion lagged behind the increase in sodium excretion, and he suggested that the increased dopamine excretion may be purely a secondary effect. Our inability to detect any change in dopamine excretion during LBPP is therefore compatible with these results. Furthermore, re-examination of Alexander's data shows the same phenomenon in that sodium excretion showed a marked increase during the first 90 min of the experiment with no change in dopamine excretion. Only much later did dopamine excretion increase with a further increase in sodium excretion. Ball et al. [19] implied that the presence of the chloride ion was important in obtaining an increase in urinary dopamine after volume-loading.
Imondi et al. found that the administration of the decarboxylase inhibitor, carbidopa, caused a significant decrease in both urinary dopamine and sodium excretion in normal subjects.
In the present study the administration of the dopamine-blocking agent, domperidone, totally abolished the natriuretic response to LBPP. On the other hand, no effect was seen on urine flow and CHz0. This implies that dopamine blockade did not interfere with the suppression of antidiuretic hormone. We were unable to find any changes in urinary dopamine excretion over the short time course of our study.
The additional study demonstrates that domperidone has no significant effect on basal sodium excretion and strongly suggests that dopamine blockade during LBPP abolishes the natriuretic response produced by this manoeuvre. A fourth possibility is the increase in plasma prolactin that dopamine-blocking agents have been shown to produce. Domperidone, metaclopramide and sulpiride all increase plasma prolactin concentration 122, 24-261. Furthermore, the administration of ovine prolactin to normal subjects has been shown to cause a marked sodium retention for up to 6 h [271. In addition, Lucci et al. 1281 found that the natriuretic response to saline expansion was significantly blunted by the prior administration of ovine prolactin. However, prolactin did not blunt the response to volume-expansion with blood. In contrast, Baumann & Loriaux [291 found that acute elevation of endogenous prolactin did not produce any reduction in sodium excretion.
On the other hand, Karmali et al.
[301 found that prolactin production showed a threefold reduction when normal subjects were placed in a hyperbaric chamber. This is a condition similar to that produced by LBPP in the present experiment.
The results of our study on the effects of dopamine blockade on basal sodium excretion would seem to exclude any major role for prolactin in its short-term regulation. As domperidone increases prolactin production, a decrease in sodium excretion might have been expected after its administration. This was not found. We are therefore unable to define by what mechanism dopamine inhibits the response to LBPP.
